论文信息 - Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption - 字舞流文

Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption

A. Pradier | F. Giannotti | Y. Chalandon | S. Masouridi-Levrat | F. Simonetta | A. Mamez | S. Morin